Press release
Hepatitis B Virus (HBV) Infection Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated)
Key Takeaways from the Hepatitis B Virus Infection Pipeline Report
*
DelveInsight's Hepatitis B Virus Infection pipeline report depicts a robust space with 80+ active players working to develop 90+ pipeline therapies for Hepatitis B Virus Infection treatment.
*
The leading companies working in the Hepatitis B Virus Infection Market include Vir Biotechnology, Arbutus Biopharma, Nucorion Pharmaceuticals, Xian Xintong Pharmaceutical Research, Dong-A ST Co. Ltd., Gilead Sciences, Antios Therapeutics, Ascletis Pharmaceuticals, Shanghai HEP Pharmaceutical, Golden Biotechnology, Sunshine Lake Pharma, Ascentage Pharma, GlaxoSmithKline, Janssen Sciences, Tasly Tianjin Biopharmaceutical, Brii Biosciences, Zhejiang Palo Alto Pharmaceuticals, PharmaEssentia, Jiangsu HengRui Medicine, Enanta Pharmaceuticals, Chong Kun Dang Pharmaceutical, Guangzhou Lupeng Pharmaceutical, Zhimeng Biopharma, Dicerna Pharmaceuticals, Altimmune, Viravaxx, Aligos Therapeutics, GC Biopharma, Immunocore, Huahui Health, PRISM Pharma, Hepion Pharmaceuticals, Hepatera, Virion Therapeutics, and others.
*
Promising Hepatitis B Virus Infection Pipeline Therapies in the various stages of development include BRII-835, EYP001a, VIR-2218, Pegylated interferon-alfa 2a, ABI-H3733, and others.
*
May 2024:- Biolytical Labotories - A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings. Participants are prospctively recruited and enrolled to participate in the study. The Capillary (fingerstick) whole blood, and venous whole blood samples (in serum separating tube (SST) and Ethylenediaminetetraacetic acid (EDTA) tube) are collected by a healthcare professional.
*
May 2024:- Gilead Sciences - A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects With Chronic Hepatitis B Virus Infection. The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with CHB and to learn more about the dosing levels in children.
Request a sample and discover the recent advances in Hepatitis B Virus Infection Treatment Drugs @ Hepatitis B Virus Infection Pipeline Report [https://www.delveinsight.com/sample-request/hepatitis-b-virus-hbv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
In the Hepatitis B Virus Infection pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Hepatitis B Virus (HBV) Infection collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Hepatitis B Virus Infection Overview
Hepatitis B viral infection is a serious global healthcare problem. It is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). Hepatitis B virus is transmitted via percutaneous inoculation or through mucosal exposure with infectious bodily fluids. Oral-fecal transmission is possible but considerably rare.
Find out more about Hepatitis B Virus Infection Therapeutics Assessment @ Hepatitis B Virus Infection Preclinical and Discovery Stage Products [https://www.delveinsight.com/sample-request/hepatitis-b-virus-hbv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Hepatitis B Virus Infection Emerging Drugs Profile
*
Bepirovirsen: GSK
*
VIR 2218: Vir Biotechnology
*
AB 729: Arbutus Biopharma
*
AHB-137: Ausper Biopharma
Hepatitis B Virus Infection Pipeline Therapeutics Assessment
There are approx. 80+ key companies which are developing the Hepatitis B Virus Infection. The Hepatitis B Virus Infection companies which have their Hepatitis B Virus Infection drug candidates in the most advanced stage, i.e. phase III include GSK.
DelveInsight's Hepatitis B Virus Infection pipeline report covers around 90+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Hepatitis B Virus Infection pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Oral
*
Intravenous
*
Subcutaneous
*
Parenteral
*
Topical
Hepatitis B Virus Infection Pipeline Products have been categorized under various Molecule types such as
*
Recombinant fusion proteins
*
Small molecule
*
Monoclonal antibody
*
Peptide
*
Polymer
*
Gene therapy
Learn more about the emerging Hepatitis B Virus Infection Pipeline Therapies @ Hepatitis B Virus Infection Clinical Trials Assessment [https://www.delveinsight.com/sample-request/hepatitis-b-virus-hbv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Hepatitis B Virus Infection Pipeline Report
*
Coverage- Global
*
Hepatitis B Virus Infection Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
*
Hepatitis B Virus Infection Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
*
Hepatitis B Virus Infection Companies- Vir Biotechnology, Arbutus Biopharma, Nucorion Pharmaceuticals, Xian Xintong Pharmaceutical Research, Dong-A ST Co. Ltd., Gilead Sciences, Antios Therapeutics, Ascletis Pharmaceuticals, Shanghai HEP Pharmaceutical, Golden Biotechnology, Sunshine Lake Pharma, Ascentage Pharma, GlaxoSmithKline, Janssen Sciences, Tasly Tianjin Biopharmaceutical, Brii Biosciences, Zhejiang Palo Alto Pharmaceuticals, PharmaEssentia, Jiangsu HengRui Medicine, Enanta Pharmaceuticals, Chong Kun Dang Pharmaceutical, Guangzhou Lupeng Pharmaceutical, Zhimeng Biopharma, Dicerna Pharmaceuticals, Altimmune, Viravaxx, Aligos Therapeutics, GC Biopharma, Immunocore, Huahui Health, PRISM Pharma, Hepion Pharmaceuticals, Hepatera, Virion Therapeutics, and others.
*
Hepatitis B Virus Infection Pipeline Therapies- BRII-835, EYP001a, VIR-2218, Pegylated interferon-alfa 2a, ABI-H3733, and others.
Dive deep into rich insights for new drugs for Hepatitis B Virus Infection Treatment, Visit @ Hepatitis B Virus Infection Market Drivers and Barriers, and Future Perspective [https://www.delveinsight.com/sample-request/hepatitis-b-virus-hbv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
*
Introduction
*
Executive Summary
*
Hepatitis B Virus Infection: Overview
*
Pipeline Therapeutics
*
Therapeutic Assessment
*
Hepatitis B Virus Infection- DelveInsight's Analytical Perspective
*
Late Stage Products (Phase III)
*
Bepirovirsen: GSK
*
Drug profiles in the detailed report.....
*
Mid Stage Products (Phase II)
*
VIR 2218: Vir Biotechnology
*
Drug profiles in the detailed report.....
*
Early Stage Products (Phase I)
*
AHB-137: Ausper Biopharma
*
Drug profiles in the detailed report.....
*
Preclinical and Discovery Stage Products
*
Drug name: Company name
*
Drug profiles in the detailed report.....
*
Inactive Products
*
Hepatitis B Virus Infection Key Companies
*
Hepatitis B Virus Infection Key Products
*
Hepatitis B Virus Infection- Unmet Needs
*
Hepatitis B Virus Infection- Market Drivers and Barriers
*
Hepatitis B Virus Infection- Future Perspectives and Conclusion
*
Hepatitis B Virus Infection Analyst Views
*
Hepatitis B Virus Infection Key Companies
*
Appendix
For further information on the Hepatitis B Virus Infection Pipeline therapeutics, reach out to Hepatitis B Virus Infection Unmet Needs and Analyst Views [https://www.delveinsight.com/sample-request/hepatitis-b-virus-hbv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hepatitis-b-virus-hbv-infection-pipeline-outlook-fda-approvals-clinical-trials-and-companies-2024-updated]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis B Virus (HBV) Infection Pipeline Outlook, FDA Approvals, Clinical Trials and Companies 2024 (Updated) here
News-ID: 3489681 • Views: …
More Releases from ABNewswire
New Fantasy Epic by Christian Dolder Takes Readers On an Epic Adventure, Transce …
Christian Dolder's book, The Legacy of the Elves, mixes friendship and mystery in an engaging fantasy setting.
Image: https://www.abnewswire.com/uploads/a72fcbb824744d03777a94228f6bf175.png
Amidst ancient valleys and hidden mysteries, a new saga unfolds in "The Chronicles of Wetherid - The Legacy of the Elves," authored by Christian Dolder. Set against the backdrop of deep valleys and hidden secrets, this epic tale follows the disappearance of a sacred book entrusted to the guardianship of the Elves. As…
Experience the Perfect Cabin Vacation and Wild Animal Safari in Pine Mountain, G …
Pine Mountain Cabins offers a luxurious and serene getaway with modern amenities on 22 private acres. Guests can enjoy nearby attractions like hiking at F.D.R. State Park and exploring the stunning Callaway Gardens. A highlight of the area is the Wild Animal Safari, a drive-thru park featuring over 75 species of exotic animals for close-up encounters.
Pine Mountain, GA - Plan an unforgettable retreat at Pine Mountain Cabins and explore the…
Crossed App is Officially Live in App Stores and Online: Revolutionizing Modern …
Meet Crossed: The App Revolutionizing How We Connect in the Modern World
Tampa, Florida - Crossed [https://justcrossed.com/], the innovative new app designed to transform the way people connect, is officially available for download in App Stores [https://apps.apple.com/us/app/crossed/id6470677406] and Online. Created by visionaries Manny Manzel and Conor Crighton, Crossed aims to address the superficiality of modern social and professional networking apps by emphasizing authenticity and proximity in every interaction.
Tired of endless swiping…
"The Veil Unveiled: Exploring Mysteries of Faith and Judgment" by George Gonzale …
Author George Gonzalez, a visionary writer, and spiritual mentor unveils another book that will journey readers about Jewish customs, fasting, observing the Sabbath, the Tallit, Messiah's Helix Code, and the Torn Veil. "KRIAH featuring "The Ancient One": 'The Mystery of the Torn Veil unleashes the hidden doorway in Kriah, all who have access are believers of Messiah Yahushua.
Gonzalez combines literary, historical, and theological approaches in this study of the doctrine…
More Releases for Vir
Investigation for NASDAQ: VIR Investors over possible Wrongdoing at Vir Biotechn …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Vir Biotechnology, Inc.
Investors who purchased shares of Vir Biotechnology, Inc. (NASDAQ: VIR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Vir Biotechnology directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Francisco, CA based…
SOFTWARE-DEFINED NETWORKING AND NETWORK FUTUALIZATION MARKET knowNCTION VIR indu …
“The SDN and NFV is picking up noticeable quality because of the developing mechanical progressions in systems administration and server farm union. SDN is a momentous systems administration design, which is ready to totally alter the current systems administration and server farm foundation. The SDN building structure is set to reclassify the systems administration framework to meet the developing number of system clients devouring a high data transfer capacity. With…
Investigation announced for Investors in shares of Vir Biotechnology, Inc. (NASD …
Vir Biotechnology, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Vir Biotechnology, Inc. (NASDAQ: VIR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Vir Biotechnology, Inc. regarding its business, its prospects and its operations were materially false…
Balancing Valves Market 2017- IMI Hydronic, Danfoss, Frese A/S, Caleffi, VIR Gro …
Apex Market Reports, recently published a detailed market research study focused on the "Balancing Valves Market" across the global, regional and country level. The report provides 360° analysis of "Balancing Valves Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Balancing Valves industry, and estimates the future trend of Balancing Valves market…
Global Manual Balancing Valves Market 2017 : IMI Hydronic, Danfoss, Frese A/S, C …
QY Market Research published, Top Manufacturers Analysis Of Bidets Research Report. A market study based on the "Manual Balancing Valves Market" across the globe, recently added to the repository of Market Research, is titled ‘Global Manual Balancing Valves Market 2017’. The research report analyses the historical as well as present performance of the worldwide Manual Balancing Valves industry, and makes predictions on the future status of Manual Balancing Valves market…
Global Automatic Balancing Valves Market Forecast 2017 - 2022 - IMI Hydronic , D …
According to Automatic Balancing Valves Market Report by Market.Biz: China Automatic Balancing Valves market sales revenue and India Automatic Balancing Valves market sales revenue is expected to register CAGRs of XX.XX % and XX.XX% respectively over the forecast period. Automatic Balancing Valves consumption in the ASEAN region's growth rate of XX.XX% outperforming many countries in the Europe and Americas on …
